Resources / Policy and regulation

The Fonagy Review: What It Means for ADHD Assessment and Regulation

Last updated: · Policy update

On 9 October 2026, the government published the final report of the Independent Review into Mental Health Conditions, ADHD and Autism. The review was chaired by Professor Peter Fonagy, with Professor Gillian Baird and Professor Sir Simon Wessely as vice-chairs. It covers services in England, was announced in December 2025, and the final report runs to 599 pages.

We have followed the review closely. This page summarises what we think matters for anyone considering an adult ADHD assessment, and explains where ADHD Reveal stands. It is a summary of the published findings: please read the report itself for the full detail.

What the review found

On overdiagnosis. The review could not conclude that overdiagnosis of ADHD and autism is happening at scale. Population prevalence data are limited and dated. It also warns that the risks of misdiagnosis and overdiagnosis need attention alongside continuing under-recognition.

On who carries out assessments. Independent providers now carry out more than half of NHS-funded ADHD assessments and more than a third of NHS-funded autism assessments, much of it through Right to Choose. The report says only around 10 of approximately 120 ADHD service providers submitted data, leaving substantial gaps in national reporting.

On quality and cost. The review raised concerns about inconsistent quality in some independent-sector assessments. It reported average GP acceptance of shared-care arrangements for medication initiated by independent providers at around 62%, citing concerns about assessment quality and ongoing specialist support. It also reported a rise of around 252% in NHS spending on independent-sector ADHD services over three years. These are findings reported by the review, not an assessment of every provider.

What it recommends

The recommendations most relevant to assessment providers include:

  • Equal standards. Consistent quality standards and oversight across NHS-funded and independent provision.
  • Regulation. Making all ADHD and autism diagnostic assessments a regulated activity overseen by the Care Quality Commission (CQC).
  • Data. More consistent reporting of activity, quality and outcomes, including independent and Right to Choose provision.
  • Advertising. A ban on direct-to-public advertising of NHS-funded ADHD and autism assessments.

In its initial response, the government also announced a proposed national tariff for NHS-funded services. NHS England intends to introduce finalised payment arrangements from April 2027, following consultation. This is an intended implementation date, not a new rule already in force, and it concerns NHS-funded care rather than setting private self-pay fees.

The review did not recommend abolishing Right to Choose. In evidence to MPs on 14 October 2026 (question 245), Professor Fonagy said it recommended prioritisation instead.

What is already happening, and what isn’t

The government issued an initial response on publication, including action to strengthen oversight and regulation of ADHD and autism assessments.

The CQC’s announcement says the Department of Health and Social Care has asked it to regulate all diagnostic assessments for ADHD and autism once new regulations are in place. It explains that current legislation allows it to regulate services offering diagnosis and treatment, but not services offering diagnosis alone.

A recommendation or announced intention is different from an implemented requirement. The CQC announcement does not give a commencement date for these new regulations. This article reflects the position checked on 7 November 2026; we will review it as further details are published.

Where ADHD Reveal stands

ADHD Reveal is an online adult ADHD assessment service for adults aged 18 and over in the UK. Our assessments use the DIVA-5 structured interview within a wider clinical assessment informed by NICE guidance. Qualified clinicians consider your history, health, everyday impact and other possible explanations, with onward referral or signposting where appropriate.

We provide assessment only. We do not prescribe or supervise medication. Decisions about any subsequent prescribing are made independently by the treatment provider.

ADHD Reveal is not currently CQC registered. The CQC’s current scope guidance states that services offering ADHD and autism diagnosis without treatment do not need to register for that activity. That is the distinction relevant to our assessment-only service.

We welcome consistent standards. A diagnosis is only useful if the person, their GP and other services can trust how it was reached. We also welcome clearer reporting, transparent pricing and the review’s recognition that people seeking answers are experiencing real difficulties.

Our assessment pathway includes pre-assessment information, clinical review and a clinician-led assessment. You can ask us about professional registration, consent, safeguarding, information sharing and how your report is prepared before deciding whether to proceed. We have a published complaints procedure, and you can contact complaints@adhdreveal.co.uk.

How we’re following the changes

We are following the government’s response and developments in regulation, data requirements, pricing and advertising. As requirements become clear, we will review our processes and information against what is adopted. If you notice anything on this page that is out of date, please let us know.

What this means if you’re considering an assessment

The review’s recommendations do not, by themselves, change the law or guarantee a particular assessment outcome. Whoever you choose, you can reasonably ask:

  • Who will carry out my assessment, and what is their professional registration?
  • How is the assessment carried out, and what will the report include?
  • How will my GP be informed, and what happens if I want to explore medication?
  • What does it cost, and what is included?
  • How are my information and any safeguarding concerns handled?

A good provider will answer these clearly and without pressure.

Sources

  1. Department of Health and Social Care: final report and executive summary. Published 9 October 2026; updated 21 October 2026. See the report’s printed pages 18 and 329 for the provider, spending and shared-care figures.
  2. Department of Health and Social Care: government’s initial response, 9 October 2026. Includes the proposed national tariff and intended April 2027 payment arrangements.
  3. CQC: plans to regulate autism and ADHD diagnostic assessments, 9 October 2026.
  4. CQC: diagnostic and screening procedures — current scope of registration.
  5. House of Commons Health and Social Care Committee: oral evidence, 14 October 2026, question 245.

← Back to Resources